Učitavanje...
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in ca...
Spremljeno u:
| Izdano u: | J Transl Med |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5175387/ https://ncbi.nlm.nih.gov/pubmed/27998273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-1100-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|